For: | Zhang XY, Yuan K, Fang YL, Wang CL. Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in a child: A case report. World J Clin Cases 2022; 10(18): 6211-6217 [PMID: 35949851 DOI: 10.12998/wjcc.v10.i18.6211] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i18/6211.htm |
Number | Citing Articles |
1 |
Tomoko Tadokoro, Joji Tani, Yudai Sato, Rie Yano, Kei Takuma, Mai Nakahara, Kyoko Oura, Koji Fujita, Masafumi Ono, Atsushi Tobiume, Seisuke Sato, Takuya Inoue, Asahiro Morishita, Hideki Kobara. Decompensated Cirrhosis with Hepatopulmonary Syndrome in a Patient with Interrupted Treatment for Hypopituitarism: A Case Report. Internal Medicine 2025; doi: 10.2169/internalmedicine.4753-24
|
2 |
Deyue Jiang, Shengjie Wang, Yan Xiao, Peng Zhi, Erhan Zheng, Zhaohui Lyu, Qinghua Guo. Risk factors and prediction model of metabolic disorders in adult patients with pituitary stalk interruption syndrome. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-91461-7
|
3 |
Yunsoo Choe, Yun Jeong Lee, Young Ah Lee, Jae Sung Ko, Choong Ho Shin. Hepatopulmonary syndrome secondary to metabolic associated fatty liver disease in childhood — novel treatment with growth hormone replacement therapy: a case report and systematic review of literature. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1407686
|